More Reyra adheres to cGMP standards, and its initial API site (Unit-1) has been inspected and approved by global regulatory agencies including:
USFDA
EU GMP
Japanese AFM
Korean FDA
State GMP
The R&D facility is recognized by DSIR.
The second API site (Unit-III), operational since 2021, is designed in accordance with cGMP guidelines and is focused on achieving compliance with global regulatory standards.